How a drug company made millions pushing an opioid painkiller up to 100 times stronger than morphine, as many on Wall Street looked the other way. FRONTLINE filmmaker Tom Jennings and Financial Times reporter Hannah Kuchler discuss their new investigation of Insys Therapeutics — from a jaw-dropping interview with a former sales director who admits to bribing doctors to prescribe the highly addictive drug Subsys, to how Wall Street propelled Insys’ success even as questions emerged about its practices, to what role drug companies’ pursuit of profits has played in the opioid crisis: “I think that it’s really interesting just how people are able to disconnect their actions from the consequences, especially in business,” Kuchler says. This journalism is made possible by viewers like you. Support your local PBS station here: www.pbs.org/donate Subscribe on YouTube: bit.ly/1BycsJW For more on Insys' spectacular rise and fall — and its consequences — watch the documentary "Opioids, Inc." here: youtu.be/WvCld2vKug8 Our in-depth joint reporting is available on the FR website at ft.com/insys and here: www.pbs.org/wgbh/frontline/article/opioid-drugmaker-insys-bribing-doctors-fentanyl-painkiller/ #Podcast #Documentary #FrontlinePBS Instagram: www.instagram.com/frontlinepbs Twitter: twitter.com/frontlinepbs Facebook: www.facebook.com/frontline FRONTLINE is streaming more than 200 documentaries online, for free, here: to.pbs.org/hxRvQP The FRONTLINE Dispatch is produced at FRONTLINE’s headquarters at WGBH in Boston and distributed by PRX, a leading podcast creator and distributor working closely with WGBH on a range of podcast initiatives. The FRONTLINE Dispatch is made possible by a generous gift from the Abrams Foundation Journalism Initiative.

Be the first to comment